Company data
Ultragenyx Pharmaceutical Inc. employees and revenue per employee
RARE · Biotechnology · $1.52B market cap
Ultragenyx Pharmaceutical Inc. had 1,371 employees at the end of fiscal Dec 2025, up 6.0% from a year earlier. Revenue for the year was $673M, up 20.1% from a year earlier, or $491K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
1,371
+6.0% YoY
Revenue
$673M
+20.1% YoY
Revenue / employee
$491K
Peer median $459K
Rank in industry
51 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 1,371 | $673M | $491K | +6.0% | +20.1% |
| Dec 2024 | 1,294 | $560M | $433K | +1.4% | +29.0% |
| Dec 2023 | 1,276 | $434M | $340K | -2.7% | +19.5% |
| Dec 2022 | 1,311 | $363M | $277K | +17.2% | +3.4% |
| Dec 2021 | 1,119 | $351M | $314K | +25.3% | +29.7% |
| Dec 2020 | 893 | $271M | $304K | +20.7% | +161.3% |
| Dec 2019 | 740 | $104M | $140K | +21.3% | +101.4% |
| Dec 2018 | 610 | $51.5M | $84K | +17.3% | +1871.5% |
| Dec 2017 | 520 | $2.6M | $5K | +38.3% | +1863.9% |
| Dec 2016 | 376 | $133,000 | $354 | — | — |
Open roles: we have not matched a verified job board for this company yet.
Ultragenyx Pharmaceutical Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 293 | $868M | $2.96M | Efficient growth |
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| MIRM Mirum Pharmaceuticals, Inc. | 369 | $521M | $1.41M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| RARE Ultragenyx Pharmaceutical Inc. | 1,371 | $673M | $491K | Efficient growth |
| INSM Insmed Incorporated | 1,664 | $606M | $364K | Efficient growth |
Questions about Ultragenyx Pharmaceutical Inc.
- How many employees does Ultragenyx Pharmaceutical Inc. have?
- Ultragenyx Pharmaceutical Inc. reported 1,371 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 18, 2026. That is up 6.0% from a year earlier.
- What is Ultragenyx Pharmaceutical Inc.'s revenue per employee?
- Ultragenyx Pharmaceutical Inc. brought in $673M of revenue in fiscal Dec 2025, which is $491K per employee. That ranks 51 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare RARE with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Ultragenyx Pharmaceutical Inc.'s annual reports (Form 10-K), latest filed February 18, 2026. This is data, not a recommendation to buy or sell RARE.